Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Butamben | hsa00061 | Fatty acid biosynthesis | 4.07E-02 | 1 | P33121 | ACSL1 | More | | Butamben | hsa00071 | Fatty acid degradation | 2.52E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Butamben | hsa00190 | Oxidative phosphorylation | 3.73E-04 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Butamben | hsa00500 | Starch and sucrose metabolism | 1.07E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Butamben | hsa00510 | N-Glycan biosynthesis | 3.15E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | | Butamben | hsa00514 | Other types of O-glycan biosynthesis | 3.20E-02 | 2 | O15294, Q9NY28 | OGT, GALNT8 | More | | Butamben | hsa00531 | Glycosaminoglycan degradation | 8.18E-04 | 2 | P15586, P34059 | GNS, GALNS | More | | Butamben | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 1.29E-03 | 1 | Q9Y2C2 | UST | More | | Butamben | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Butamben | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Butamben | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 1.34E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | | Butamben | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.12E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Butamben | hsa00730 | Thiamine metabolism | 8.96E-04 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Butamben | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | | Butamben | hsa00770 | Pantothenate and CoA biosynthesis | 2.27E-02 | 2 | O95498, O95497 | VNN2, VNN1 | More | | Butamben | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.77E-04 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Butamben | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.20E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Butamben | hsa00982 | Drug metabolism - cytochrome P450 | 3.20E-02 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Butamben | hsa01100 | Metabolic pathways | 2.61E-03 | 32 | P05089, O14521, O95455, P21953, P32320, Q13370, P11766, P06280, Q16875, O43286, O43451, P11712, P05186, P24666, P23743, O60701, Q9HCC0, P33121, Q08477, P15907, Q9NY28, Q9UNP4, P09960, P37837, P32321, Q9BPW9, Q9UHY7, P43490, Q9Y2B2, P46976, P06737, Q16718 | ARG1, SDHD, TGDS, BCKDHB, CDA, PDE3B, ADH5, GLA, PFKFB3, B4GALT5, MGAM, CYP2C9, ALPL, ACP1, DGKA, UGDH, MCCC2, ACSL1, CYP4F3, ST6GAL1, GALNT8, ST3GAL5, LTA4H, TALDO1, DCTD, DHRS9, ENOPH1, PBEF1, PIGL, GYG1, PYGL, NDUFA5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P05089 | ARG1 | Arginase-1 | 0.807 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.706 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O95455 | TGDS | dTDP-D-glucose 4,6-dehydratase | -0.716 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P21953 | BCKDHB | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | -0.709 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P32320 | CDA | Cytidine deaminase | 0.714 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0.728 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | -0.857 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P06280 | GLA | Alpha-galactosidase A | 0.706 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.919 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.779 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O43451 | MGAM | Maltase-glucoamylase | 0.925 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P11712 | CYP2C9 | Cytochrome P450 2C9 | 0.733 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.883 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.715 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | 0.726 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P23743 | DGKA | Diacylglycerol kinase alpha | -0.75 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | O60701 | UGDH | UDP-glucose 6-dehydrogenase | 0.725 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.71 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.74 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | -0.722 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q08477 | CYP4F3 | Cytochrome P450 4F3 | 0.793 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.722 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | Q9NY28 | GALNT8 | Probable polypeptide N-acetylgalactosaminyltransferase 8 | 0.817 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.726 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | P09960 | LTA4H | Leukotriene A-4 hydrolase | -0.771 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P37837 | TALDO1 | Transaldolase | 0.843 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P32321 | DCTD | Deoxycytidylate deaminase | -0.737 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.899 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.709 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.899 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | Q9Y2B2 | PIGL | N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase | 0.761 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P46976 | GYG1 | Glycogenin-1 | 0.866 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.783 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.794 |
| Butamben | hsa01524 | Platinum drug resistance | 3.62E-02 | 4 | Q13489, P98170, P78417, P43246 | BIRC3, BIRC4, GSTO1, MSH2 | More | | Butamben | hsa03008 | Ribosome biogenesis in eukaryotes | 2.06E-02 | 2 | Q9NYH9, Q9BVP2 | UTP6, GNL3 | More | | Butamben | hsa03010 | Ribosome | 1.03E-02 | 2 | P46777, P50914 | RPL5, RPL14 | More | | Butamben | hsa03022 | Basal transcription factors | 2.17E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Butamben | hsa03040 | Spliceosome | 3.17E-02 | 6 | Q14562, O43143, Q07955, Q13243, P11142, O75643 | DHX8, DHX15, SFRS1, SFRS5, HSPA8, ASCC3L1 | More | | Butamben | hsa03050 | Proteasome | 3.93E-02 | 1 | P62195 | PSMC5 | More | | Butamben | hsa04012 | ErbB signaling pathway | 4.28E-02 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | | Butamben | hsa04014 | Ras signaling pathway | 4.38E-02 | 5 | P20827, P49767, Q14644, P0DP23, P62873 | EFNA1, VEGFC, RASA3, CALM1, GNB1 | More | | Butamben | hsa04020 | Calcium signaling pathway | 4.93E-02 | 3 | P17252, P25116, P20020 | PRKCA, F2R, ATP2B1 | More | | Butamben | hsa04024 | cAMP signaling pathway | 4.93E-02 | 3 | P20020, Q13370, P25116 | ATP2B1, PDE3B, F2R | More | | Butamben | hsa04060 | Cytokine-cytokine receptor interaction | 4.71E-02 | 2 | P78552, O75509 | IL13RA1, TNFRSF21 | More | | Butamben | hsa04064 | NF-kappa B signaling pathway | 2.63E-03 | 11 | P10415, O00463, P01375, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q13315, P24522, P09341 | BCL2, TRAF5, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, ATM, GADD45A, CXCL1 | More | | Butamben | hsa04070 | Phosphatidylinositol signaling system | 2.56E-02 | 4 | P19174, P0DP23, P23743, P27987 | PLCG1, CALM1, DGKA, ITPKB | More | | Butamben | hsa04072 | Phospholipase D signaling pathway | 1.54E-03 | 5 | Q92529, P25116, P17252, Q14344, P23743 | SHC3, F2R, PRKCA, GNA13, DGKA | More | | Butamben | hsa04140 | Autophagy - animal | 4.55E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Butamben | hsa04141 | Protein processing in endoplasmic reticulum | 3.07E-02 | 5 | P30101, P60604, P11142, P08238, Q9UNL2 | PDIA3, UBE2G2, HSPA8, HSP90AB1, SSR3 | More | | Butamben | hsa04142 | Lysosome | 1.14E-02 | 3 | P43234, P15586, P34059 | CTSO, GNS, GALNS | More | | Butamben | hsa04145 | Phagosome | 3.69E-02 | 7 | O75015, Q15080, P05164, P78380, O60603, P35443, P13765 | FCGR3B, NCF4, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Butamben | hsa04150 | mTOR signaling pathway | 4.38E-04 | 5 | P42338, Q9NQL2, Q13322, P49841, Q93098 | PIK3CB, RRAGD, GRB10, GSK3B, WNT8B | More | | Butamben | hsa04210 | Apoptosis | 9.18E-03 | 4 | P04637, P24522, P43234, P63261 | TP53, GADD45A, CTSO, ACTG1 | More | | Butamben | hsa04217 | Necroptosis | 2.87E-03 | 8 | P01568, Q13489, P42224, P08238, Q6FI13, Q93077, O43633, Q08752 | IFNA21, BIRC3, STAT1, HSP90AB1, H2AC18; H2AC19, HIST1H2AC, CHMP2A, PPID | More | | Butamben | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.29E-02 | 3 | P09493, P17252, P20020 | TPM1, PRKCA, ATP2B1 | More | | Butamben | hsa04371 | Apelin signaling pathway | 5.32E-04 | 8 | P62873, P63218, Q13370, Q14814, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, PDE3B, MEF2D, SMAD4, SMAD3, CAMK4, CALM1 | More | | Butamben | hsa04380 | Osteoclast differentiation | 4.80E-02 | 4 | P06239, P42338, P14778, Q8N149 | LCK, PIK3CB, IL1R1, LILRA2 | More | | Butamben | hsa04610 | Complement and coagulation cascades | 4.69E-03 | 1 | P0C0L4 | C4A | More | | Butamben | hsa04612 | Antigen processing and presentation | 3.69E-02 | 7 | P13765, P48382, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Butamben | hsa04613 | Neutrophil extracellular trap formation | 2.16E-02 | 7 | P19174, P11215, Q13547, Q93077, P62807, O60814, P60709 | PLCG1, ITGAM, HDAC1, HIST1H2AC, HIST1H2BC, H2BC12, ACTB | More | | Butamben | hsa04621 | NOD-like receptor signaling pathway | 1.93E-02 | 8 | Q16539, P10599, Q9H1Y0, P43490, O00463, P01375, P09341, P12838 | MAPK14, TXN, ATG5, PBEF1, TRAF5, TNF, CXCL1, DEFA4 | More | | Butamben | hsa04623 | Cytosolic DNA-sensing pathway | 3.15E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Butamben | hsa04640 | Hematopoietic cell lineage | 4.09E-03 | 10 | P13612, P27930, P15144, P25063, P04234, P09693, P01732, P13765, P20036, P01375 | ITGA4, IL1R2, ANPEP, CD24, CD3D, CD3G, CD8A, HLA-DOB, HLA-DPA1, TNF | More | | Butamben | hsa04650 | Natural killer cell mediated cytotoxicity | 1.19E-02 | 9 | P01375, P06239, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, LCK, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Butamben | hsa04657 | IL-17 signaling pathway | 1.05E-03 | 10 | P08238, O00463, Q07955, Q16539, P49841, P09341, P14780, Q9UJX4, P04141, P01375 | HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL1, MMP9, ANAPC5, CSF2, TNF | More | | Butamben | hsa04658 | Th1 and Th2 cell differentiation | 5.05E-05 | 15 | Q04759, P07766, P04234, P20963, P09693, P19174, P06239, P42224, Q14765, P23771, Q9UL17, P14784, P13765, P20036, Q13761 | PRKCQ, CD3E, CD3D, CD247, CD3G, PLCG1, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, HLA-DPA1, RUNX3 | More | | Butamben | hsa04659 | Th17 cell differentiation | 3.43E-05 | 16 | Q04759, P19174, P06239, P42224, P14784, P13765, P20036, P14778, Q9HBE5, Q9UL17, P23771, P08238, P07766, P09693, P04234, P20963 | PRKCQ, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, HLA-DPA1, IL1R1, IL21R, TBX21, GATA3, HSP90AB1, CD3E, CD3G, CD3D, CD247 | More | | Butamben | hsa04660 | T cell receptor signaling pathway | 4.75E-03 | 10 | P01375, Q9UDY8, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, P06239 | TNF, MALT1, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, LCK | More | | Butamben | hsa04662 | B cell receptor signaling pathway | 7.25E-03 | 4 | P49841, P42338, P21854, Q8N149 | GSK3B, PIK3CB, CD72, LILRA2 | More | | Butamben | hsa04672 | Intestinal immune network for IgA production | 3.16E-02 | 1 | P20036 | HLA-DPA1 | More | | Butamben | hsa04714 | Thermogenesis | 1.99E-02 | 3 | P33121, Q16718, O14521 | ACSL1, NDUFA5, SDHD | More | | Butamben | hsa04721 | Synaptic vesicle cycle | 3.15E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Butamben | hsa04726 | Serotonergic synapse | 1.64E-02 | 3 | P17252, P31645, P11712 | PRKCA, SLC6A4, CYP2C9 | More | | Butamben | hsa04730 | Long-term depression | 3.52E-02 | 1 | Q14344 | GNA13 | More | | Butamben | hsa04744 | Phototransduction | 5.04E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Butamben | hsa04750 | Inflammatory mediator regulation of TRP channels | 9.08E-03 | 4 | P14778, P42338, Q9Y5S1, P24723 | IL1R1, PIK3CB, TRPV2, PRKCH | More | | Butamben | hsa04919 | Thyroid hormone signaling pathway | 2.48E-02 | 5 | P19174, P42224, P60709, Q13547, P01106 | PLCG1, STAT1, ACTB, HDAC1, MYC | More | | Butamben | hsa04929 | GnRH secretion | 3.63E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Butamben | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.33E-02 | 4 | P84022, Q13485, Q12778, P49767 | SMAD3, SMAD4, FOXO1, VEGFC | More | | Butamben | hsa04940 | Type I diabetes mellitus | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | | Butamben | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | | Butamben | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.48E-02 | 2 | P20020, P17252 | ATP2B1, PRKCA | More | | Butamben | hsa04970 | Salivary secretion | 4.83E-02 | 2 | P20020, P17252 | ATP2B1, PRKCA | More | | Butamben | hsa04972 | Pancreatic secretion | 1.48E-02 | 2 | P20020, P17252 | ATP2B1, PRKCA | More | | Butamben | hsa04973 | Carbohydrate digestion and absorption | 4.12E-03 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Butamben | hsa05010 | Alzheimer disease | 1.23E-02 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Butamben | hsa05012 | Parkinson disease | 7.44E-03 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Butamben | hsa05014 | Amyotrophic lateral sclerosis | 2.32E-04 | 3 | P17861, P62195, Q53GS7 | XBP1, PSMC5, GLE1 | More | | Butamben | hsa05016 | Huntington disease | 2.93E-02 | 4 | Q16718, O14521, O00268, Q13561 | NDUFA5, SDHD, TAF4, DCTN2 | More | | Butamben | hsa05017 | Spinocerebellar ataxia | 1.95E-03 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Butamben | hsa05022 | Pathways of neurodegeneration - multiple diseases | 4.41E-03 | 7 | Q16718, O14521, P17861, Q13561, P17252, Q08752, P62195 | NDUFA5, SDHD, XBP1, DCTN2, PRKCA, PPID, PSMC5 | More | | Butamben | hsa05032 | Morphine addiction | 1.90E-02 | 4 | P62873, P63218, Q13370, P43250 | GNB1, GNG5, PDE3B, GRK6 | More | | Butamben | hsa05034 | Alcoholism | 2.43E-04 | 9 | Q16566, Q13547, P0DP23, P62873, P63218, Q93077, P62807, O60814, P68431 | CAMK4, HDAC1, CALM1, GNB1, GNG5, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Butamben | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.27E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Butamben | hsa05133 | Pertussis | 1.88E-02 | 3 | P11215, P0DP23, P23528 | ITGAM, CALM1, CFL1 | More | | Butamben | hsa05134 | Legionellosis | 4.28E-02 | 3 | P11215, P11142, P19875 | ITGAM, HSPA8, CXCL2 | More | | Butamben | hsa05140 | Leishmaniasis | 1.29E-04 | 12 | P13612, O75015, P14598, P42224, P13765, O60603, P25963, P01375, P29350, P49006, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MARCKSL1, MAPK14, NCF4 | More | | Butamben | hsa05142 | Chagas disease | 4.93E-02 | 1 | P04234 | CD3D | More | | Butamben | hsa05144 | Malaria | 1.14E-02 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Butamben | hsa05146 | Amoebiasis | 2.30E-03 | 8 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Butamben | hsa05150 | Staphylococcus aureus infection | 4.36E-02 | 2 | P0C0L4, P13646 | C4A, KRT13 | More | | Butamben | hsa05163 | Human cytomegalovirus infection | 3.28E-02 | 7 | P01375, P50151, P49841, P14778, P25025, Q16539, O00463 | TNF, GNG10, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | | Butamben | hsa05166 | Human T-cell leukemia virus 1 infection | 9.87E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | | Butamben | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 8.64E-03 | 7 | P42224, P62873, P63218, P19875, P19174, P01106, P0DP23 | STAT1, GNB1, GNG5, CXCL2, PLCG1, MYC, CALM1 | More | | Butamben | hsa05168 | Herpes simplex virus 1 infection | 3.38E-03 | 12 | P25963, P01568, Q05823, P42224, Q07955, Q13243, Q13489, Q13398, Q9HCX3, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS5, BIRC3, ZNF211, ZNF304, ZNF140, ZNF189, ZNF212 | More | | Butamben | hsa05169 | Epstein-Barr virus infection | 2.48E-03 | 9 | P20036, P01106, Q13547, P30101, Q13761, O75293, P42224, P04234, P07766 | HLA-DPA1, MYC, HDAC1, PDIA3, RUNX3, GADD45B, STAT1, CD3D, CD3E | More | | Butamben | hsa05200 | Pathways in cancer | 6.13E-04 | 20 | Q13751, P08238, P42224, P19174, P01106, P43246, P84022, Q13485, P20585, Q13547, Q13489, P98170, P49767, Q12778, P62873, P63218, P78417, O75293, P0DP23, P14784 | LAMB3, HSP90AB1, STAT1, PLCG1, MYC, MSH2, SMAD3, SMAD4, MSH3, HDAC1, BIRC3, BIRC4, VEGFC, FOXO1, GNB1, GNG5, GSTO1, GADD45B, CALM1, IL2RB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.732 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.869 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.725 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.851 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P01106 | MYC | Myc proto-oncogene protein | 0.834 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.724 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.736 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.708 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.749 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P20585 | MSH3 | DNA mismatch repair protein Msh3 | 0.731 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Q13547 | HDAC1 | Histone deacetylase 1 | 0.7 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.741 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | -0.7 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.811 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | Q12778 | FOXO1 | Forkhead box protein O1 | -0.7 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.725 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.767 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.756 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.913 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.787 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.744 | O75832 | PSMD10 | 26S proteasome non-ATPase regulatory subunit 10 | P0DP23 | CALM1 | Calmodulin-1 | 0.739 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.842 |
| Butamben | hsa05202 | Transcriptional misregulation in cancer | 2.35E-02 | 12 | Q13315, P14780, P27930, Q15744, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | ATM, MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Butamben | hsa05203 | Viral carcinogenesis | 3.56E-02 | 6 | P06746, P29083, Q13547, P12814, P62807, O60814 | POLB, GTF2E1, HDAC1, ACTN1, HIST1H2BC, H2BC12 | More | | Butamben | hsa05205 | Proteoglycans in cancer | 4.43E-02 | 3 | P63261, P04637, Q06124 | ACTG1, TP53, PTPN11 | More | | Butamben | hsa05206 | MicroRNAs in cancer | 3.17E-02 | 6 | P30304, P09493, P01106, Q9Y4H2, Q13547, P19174 | CDC25A, TPM1, MYC, IRS2, HDAC1, PLCG1 | More | | Butamben | hsa05211 | Renal cell carcinoma | 7.75E-03 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Butamben | hsa05212 | Pancreatic cancer | 2.60E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Butamben | hsa05213 | Endometrial cancer | 2.60E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Butamben | hsa05214 | Glioma | 3.46E-04 | 7 | P09619, P0DP23, Q02750, P04637, P19174, P24522, O75293 | PDGFRB, CALM1, MAP2K1, TP53, PLCG1, GADD45A, GADD45B | More | | Butamben | hsa05216 | Thyroid cancer | 1.14E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Butamben | hsa05217 | Basal cell carcinoma | 2.06E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Butamben | hsa05218 | Melanoma | 3.52E-04 | 4 | P09619, P04637, Q02750, P24522 | PDGFRB, TP53, MAP2K1, GADD45A | More | | Butamben | hsa05220 | Chronic myeloid leukemia | 7.90E-03 | 3 | Q06124, P04637, P24522 | PTPN11, TP53, GADD45A | More | | Butamben | hsa05223 | Non-small cell lung cancer | 3.19E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Butamben | hsa05224 | Breast cancer | 4.51E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Butamben | hsa05225 | Hepatocellular carcinoma | 2.06E-03 | 5 | Q92529, P04637, P24522, P51531, P63261 | SHC3, TP53, GADD45A, SMARCA2, ACTG1 | More | | Butamben | hsa05230 | Central carbon metabolism in cancer | 4.10E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | | Butamben | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.93E-02 | 1 | P04234 | CD3D | More | | Butamben | hsa05310 | Asthma | 1.20E-02 | 4 | P13765, P20036, P12724, P01375 | HLA-DOB, HLA-DPA1, RNASE3, TNF | More | | Butamben | hsa05320 | Autoimmune thyroid disease | 3.60E-02 | 1 | P20036 | HLA-DPA1 | More | | Butamben | hsa05321 | Inflammatory bowel disease | 1.40E-04 | 8 | O60603, P01375, P13765, P20036, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, HLA-DPA1, STAT4, TBX21, GATA3, IL21R | More | | Butamben | hsa05322 | Systemic lupus erythematosus | 4.50E-02 | 4 | Q93077, P62807, O60814, P12814 | HIST1H2AC, HIST1H2BC, H2BC12, ACTN1 | More | | Butamben | hsa05330 | Allograft rejection | 3.60E-02 | 1 | P20036 | HLA-DPA1 | More | | Butamben | hsa05332 | Graft-versus-host disease | 1.57E-02 | 5 | P13765, P20036, P01375, P26715, Q13241 | HLA-DOB, HLA-DPA1, TNF, KLRC1, KLRD1 | More | | Butamben | hsa05340 | Primary immunodeficiency | 1.81E-02 | 1 | P04234 | CD3D | More | | Butamben | hsa05415 | Diabetic cardiomyopathy | 1.24E-03 | 6 | P17252, P14598, Q15080, Q16718, O14521, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH | More | | Butamben | hsa05416 | Viral myocarditis | 4.49E-02 | 1 | P20036 | HLA-DPA1 | More | | Butamben | hsa05418 | Fluid shear stress and atherosclerosis | 2.43E-03 | 7 | Q16539, P42338, P10599, P14780, P01375, P14778, P27930 | MAPK14, PIK3CB, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |